Simple jQuery Dropdowns

Browsing by Author Jeffrey R. Currier

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 2 to 6 of 6 < previous 
Issue DateTitleAuthor(s)
10-Feb-2015Identification of immunodominant cd4-restricted epitopes co-located with antibody binding sites in individuals vaccinated with ALVAC-HIV and AIDSVAX B/ESilvia Ratto-Kim; Mark S. De Souza; Jeffrey R. Currier; Nicos Karasavvas; John Sidney; Morgane Rolland; Anais Valencia-Micolta; Sirinan Madnote; Alessandro Sette; Sorachai Nitayaphan; Punnee Pitisuttuthum; Jaranit Kaewkungwal; Supachai Rerks-Ngarm; Robert O'Connell; Nelson Michael; Merlin L. Robb; Mary Marovich; Jerome H. Kim; Walter Reed Army Institute of Research; Armed Forces Research Institute of Medical Sciences, Thailand; La Jolla Institute for Allergy and Immunology; Mahidol University; Thailand Ministry of Public Health; National Institutes of Health, Bethesda; National Institute of Infectious Diseases; Water Reed Army Institute of Research
2-May-2011Innate and adaptive immune responses both contribute to pathological cd4 t cell activation in hiv-1 infected ugandansMichael A. Eller; Kim G. Blom; Veronica D. Gonzalez; Leigh Anne Eller; Prossy Naluyima; Oliver Laeyendecker; Thomas C. Quinn; Noah Kiwanuka; David Serwadda; Nelson K. Sewankambo; Boonrat Tasseneetrithep; Maria J. Wawer; Ronald H. Gray; Mary A. Marovich; Nelson L. Michael; Mark S. de Souza; Fred Wabwire-Mangen; Merlin L. Robb; Jeffrey R. Currier; Johan K. Sandberg; Makerere University; U.S. Military HIV Research Program; Karolinska University Hospital; National Institute of Allergy and Infectious Diseases; The Johns Hopkins School of Medicine; Uganda Virus Research Institut; Mahidol University; Columbia University Medical Center; Johns Hopkins University; Armed Forces Research Institute of Medical Sciences, Thailand
9-Dec-2010Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia ankara-HIV-1 vaccine candidateJeffrey R. Currier; Viseth Ngauy; Mark S. de Souza; Silvia Ratto-Kim; Josephine H. Cox; Victoria R. Polonis; Patricia Earl; Bernard Moss; Sheila Peel; Bonnie Slike; Somchai Sriplienchan; Prasert Thongcharoen; Robert M. Paris; Merlin L. Robb; Jerome Kim; Nelson L. Michael; Mary A. Marovich; US MIlitary HIV Research Program/Henry M. Jackson Foundation; Armed Forces Research Institute of Medical Sciences, Thailand; International AIDS Vaccine Initiative; National Institute of Allergy and Infectious Diseases; Mahidol University
1-Nov-2012The thai phase III HIV type 1 vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120Nicos Karasavvas; Erik Billings; Mangala Rao; Constance Williams; Susan Zolla-Pazner; Robert T. Bailer; Richard A. Koup; Sirinan Madnote; Duangnapa Arworn; Xiaoying Shen; Georgia D. Tomaras; Jeffrey R. Currier; Mike Jiang; Craig Magaret; Charla Andrews; Raphael Gottardo; Peter Gilbert; Timothy J. Cardozo; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Punnee Pitisuttithum; Jaranit Kaewkungwal; Robert Paris; Kelli Greene; Hongmei Gao; Sanjay Gurunathan; Jim Tartaglia; Faruk Sinangil; Bette T. Korber; David C. Montefiori; John R. Mascola; Merlin L. Robb; Barton F. Haynes; Viseth Ngauy; Nelson L. Michael; Jerome H. Kim; Mark S. De Souza; Armed Forces Research Institute of Medical Sciences, Thailand; HJF; Walter Reed Army Institute of Research; NYU School of Medicine; Veterans Affairs NY Harbor Healthcare System; National Institute of Allergy and Infectious Diseases; Duke University School of Medicine; Fred Hutchinson Cancer Research Center; Thailand Ministry of Public Health; Mahidol University; Walter Reed National Military Medical Center; Sanofi Pasteur; Global Solutions for Infectious Diseases; Los Alamos National Laboratory
15-May-2012The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelopeMark S. De Souza; Silvia Ratto-Kim; Weerawan Chuenarom; Alexandra Schuetz; Somsak Chantakulkij; Bessara Nuntapinit; Anais Valencia-Micolta; Doris Thelian; Sorachai Nitayaphan; Punnee Pitisuttithum; Robert M. Paris; Jaranit Kaewkungwal; Nelson L. Michael; Supachai Rerks-Ngarm; Bonnie Mathieson; Mary Marovich; Jeffrey R. Currier; Jerome H. Kim; Supamit Chunsuttiwat; Nakorn Premsri; Chawetsan Namwat; Prayura Kunasol; Prasert Thongcharoen; Chirasak Khamboonruang; Valai Bussaratid; Wirach Maek-a-nantawat; Jittima Dhitavat; Pravan Suntharasamai; Swangjai Pungpak; Siriwan Vanijanonta; Jaranit Kaewkunwal; Amnat Khamsiriwatchara; Pawinee Jarujareet; Chirapa Easmila; Suchana Tabprasit; Viseth Ngauy; Robert Paris; Michael Benenson; Patricia Morgan; Arthur Brown; Mark De Souza; Rapee Trichavaroj; Nusara Thaitawat; Kanyasiri Kongnonkok; Boot Keawboon; Yuwadee Phuang-Ngern; Susan Mason; Sanjay Gurunathan; Jim Tartaglia; John G. McNeil; Robin Harkness; Claude Meric; Lynn Baglyos; Raphaelle El Habib; Don Francis; Carter Lee; Elizabeth Adams; Merlin L. Robb; Mark Milazzo; Amy Bolen; Beryl Wessner; Jeffrey Currier; Deborah L. Birx; Don Stablein; Terry Germanson; Len Dally; Jean Louis Excler; Jeffrey Berenberg; Armed Forces Research Institute of Medical Sciences, Thailand; Walter Reed Army Institute of Research; Mahidol University; Thailand Ministry of Public Health; National Institutes of Health, Bethesda; Sanofi Pasteur; Sanofi Pasteur; Global Solutions in Infectious Diseases; National Institute of Allergy and Infectious Diseases; U.S. Army Medical Research and Materiel Command; Centers for Disease Control and Prevention; The EMMES Corporation; International AIDS Vaccine Initiative; Tripler Regional Med Center